DOOR syndrome concomitant with non-convulsive status epilepticus and hyperintense cerebellar cortex on T2-weighted imaging

Brain and Development

Volumn 31, Issue 1, 2009, Pages 75-78

  Nomura, Takayasu ^a   Koyama, Norihisa ^a   Yokoyama, Machiko ^a   Awaya, Atsuko ^a   Yokochi, Kenji ^a  

^a TOYOHASHI MUNICIPAL HOSPITAL   (Japan)

Author keywords

Cerebellar atrophy; DOOR syndrome; Non convulsive status epilepticus

Indexed keywords

CARBAMAZEPINE; CLONAZEPAM; DIAZEPAM; MIDAZOLAM; PHENOBARBITAL; PHENYTOIN;

ARTICLE; BRAIN ATROPHY; CASE REPORT; CEREBELLUM CORTEX; DIFFUSION WEIGHTED IMAGING; ELECTROENCEPHALOGRAM; EPILEPTIC STATE; HUMAN; JAPAN; MALE; MARINESCO SJOGREN SYNDROME; MENTAL DEFICIENCY; METABOLIC DISORDER; NEUROAXONAL DYSTROPHY; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; SCHOOL CHILD; SYNDROME DOOR;

ABNORMALITIES, MULTIPLE; ATROPHY; CEREBELLAR CORTEX; CHILD; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; STATUS EPILEPTICUS; SYNDROME;

EID: 57349161973     PISSN: 03877604     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.braindev.2008.03.006     Document Type: Article

References (13)

1. Qazi Q.H., and Smithwick E.M. Triphalangy of thumbs and great toes. Am J Dis Child 120 (1970) 255-257
2. Walbaum R., Fontaine G., Lienhardt J., and Piquet J.J. Familial deafness with osteo-onycho-dysplasia. J Genet Hum 18 (1970) 101-108
3. Cantwell R.J. Congenital sensori-neural deafness associated with onycho-osteo dystrophy and mental retardation (DOOR syndrome). Humangenetik 26 (1975) 261-265
4. Patton M.A., Krywawych S., Winter R.M., Brenton D.P., and Baraitser M. DOOR syndrome (deafness, onycho-osteodystrophy, and mental retardation): elevated plasma and urinary 2-oxoglutarate in three unrelated patients. Am J Med Genet 26 (1987) 207-215
5. Rajab A., Riaz A., Paul G., Al-Khusaibi S., Chalmers R., and Patton M.A. Further delineation of the DOOR syndrome. Clin Dysmorphol 9 (2000) 247-251
6. Kaplan P.W. The clinical features, diagnosis, and prognosis of nonconvulsive status epilepticus. Neurologist 11 (2005) 348-361
7. Felix T.M., de Menezes Karam S., Della Rosa V.A., and Moraes A.M.S.M. DOOR syndrome: report of three additional cases. Clin Dysmorphol 11 (2002) 133-138
8. Surendran S., Michals-Matalon K., Krywawych S., Qazi Q.H., Tuchman R., Rady P.L., et al. DOOR syndrome: deficiency of E1 component of the 2-oxoglutarate dehydrogenase complex. Am J Med Genet 113 (2002) 371-374
9. James A.W., Miranda S.G., Culver K., Hall B.D., and Golabi M. DOOR syndrome: clinical report, literature review and discussion of natural history. Am J Med Genet A 143 (2007) 2821-2831
10. Ney G.C., Lantos G., Barr W.B., and Schaul N. Cerebellar atrophy in patients with long-term phenytoin exposure and epilepsy. Arch Neurol 51 (1994) 767-771
11. Tanabe Y., Iai M., Ishii M., Tamai K., Maemoto T., Ooe K., et al. The use of magnetic resonance imaging in diagnosing infantile neuroaxonal dystrophy. Neurology 43 (1993) 110-113
12. Harting I., Blaschek A., Wolf N.I., Seitz A., Haupt M., Goebel H.H., et al. T2-hyperintense cerebellar cortex in Marinesco-Sjogren syndrome. Neurology 63 (2004) 2448-2449
13. Walker M., Cross H., Smith S., Young C., Aicardi J., Appleton R., et al. Nonconvulsive status epilepticus: Epilepsy Research Foundation workshop reports. Epileptic Disord 7 (2005) 253-296